RNASE3 and colitis: Experimentally, neutralization of ECP has been shown to reduce colitis severity in animal models: Shichijo et al. demonstrated that administering antibodies against ECP ameliorated colonic inflammation in a dextran sulfate sodium rat model of colitis [17].